We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$772M
AUM Growth
+$83.7M
Cap. Flow
+$20M
Cap. Flow %
2.59%
Top 10 Hldgs %
23.79%
Holding
277
New
30
Increased
91
Reduced
113
Closed
31

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.37M
2
UNH icon
UnitedHealth
UNH
+$6.9M
3
SYK icon
Stryker
SYK
+$5.97M
4
AMZN icon
Amazon
AMZN
+$5.71M
5
NVO
Novo Nordisk
NVO
+$4.09M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.39M
2
NXPI icon
NXP Semiconductors
NXPI
+$5.81M
3
ABT icon
Abbott
ABT
+$5.43M
4
SPLK
Splunk Inc
SPLK
+$5.14M
5
HOLX
Hologic
HOLX
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 21.16%
2 Healthcare 14.53%
3 Financials 8.29%
4 Industrials 8.18%
5 Communication Services 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGR
276
DELISTED
Avangrid, Inc.
AGR
– –
-66,821
Closed -$2.02M
LTHM
277
DELISTED
Livent Corporation
LTHM
– –
-11,985
Closed -$221K
8 9 10 11
12

Similar funds

SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Greenwood Capital Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Greenwood Capital Associates held 277 positions worth $772M, up 12% from $688M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Greenwood Capital Associates's Q4 2023 filing shows 30 new, 91 increased, 113 reduced and 31 closed positions. Its largest new stake was UnitedHealth: 12,932 shares worth $6.81M. The largest sale was Thermo Fisher Scientific, an estimated $6.39M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q4 2023 buy was UnitedHealth: 12,932 shares worth $6.81M.
  • Greenwood Capital Associates added most to Berkshire Hathaway Class B in Q4 2023, an estimated $8.37M increase.
  • Greenwood Capital Associates's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $6.39M.
  • Greenwood Capital Associates fully exited NXP Semiconductors in Q4 2023, selling an estimated $5.81M.
  • Greenwood Capital Associates's ten largest holdings make up 24% of its $772M portfolio in Q4 2023.
  • Greenwood Capital Associates opened 30 new positions and closed 31 in Q4 2023.
  • Greenwood Capital Associates's portfolio value rose 12% quarter-over-quarter to $772M.

Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.